Stay updated on RPT193 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the RPT193 in Atopic Dermatitis Clinical Trial page.

Latest updates to the RPT193 in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedLocations were updated to add and remove multiple U.S. sites (Alabama, Arizona, California, Florida, Indiana, Louisiana, Massachusetts, New York, Oklahoma, Texas). The page revision note changed from v3.3.2 to v3.3.3.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no visible changes to study content or user workflow.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved a site-wide notice about potential delays due to funding gaps and about where to find operating status updates (cc.nih.gov and opm.gov). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedNo additions or deletions detected between the two screenshots. The page content appears unchanged.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference5%

- Check90 days agoChange Detected- Added Revision: v3.1.0. - Removed topics: MedlinePlus related topics: Drug Safety; Counterfeit Drugs; Pharmaceutical Preparations; Substandard Drugs; Revision: v3.0.2.SummaryDifference0.8%

Stay in the know with updates to RPT193 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RPT193 in Atopic Dermatitis Clinical Trial page.